Search Within

Victor Reuter

  1. "Biostatistics Service"
Formats
  1. Journal Article (71)
  2. Meeting Abstract (48)
  3. Conference Paper (1)
Groups
  1. Biostatistics Service (120)
  2. Department of Pathology and Laboratory Medicine (120)
  3. Epidemiology and Biostatistics (120)
  4. Surgery (90)
  5. Urology (89)
  6. Department of Medicine (77)

More Groups

People
  1. Satish Tickoo (39)
  2. Hikmat Al-Ahmadie (38)
  3. Samson Fine (32)
  4. Irina Ostrovnaya (30)
  5. Peter Scardino (29)
  6. Anuradha Gopalan (28)

More People

Years
  1. 2024 (2)
  2. 2022 (4)
  3. 2021 (5)
  4. 2020 (4)
  5. 2019 (9)
  6. 2018 (7)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Modern Pathology (11)
  3. Laboratory Investigation (9)
  4. Clinical Cancer Research (6)
  5. Journal of Urology (6)
  6. International Journal of Radiation Oncology, Biology, Physics (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. Elsevier Science, Inc. (16)
  3. American Association for Cancer Research (14)
  4. Nature Publishing Group (14)
  5. Nature Research (11)
  6. Elsevier Inc. (9)

More Publishers

Results (120)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
    Journal Article

    Kim, P. H.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Zabor, E. C.; Scott, S. N.; Ostrovnaya, I.; Ramirez, R.; Sun, A.; Shah, R.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Somatic ERCC2 mutations confer cisplatin sensitivity in muscle-invasive urothelial cancer
    Meeting Abstract

    Mouw, K.; Van Allen, E.; O'connor, K.; Wagle, N.; Kim, P.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Iyer, G.; Signoretti, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma
    Journal Article

    Van Allen, E. M.; Mouw, K. W.; Kim, P.; Iyer, G.; Wagle, N.; Al-Ahmadie, H.; Zhu, C.; Ostrovnaya, I.; Kryukov, G. V.; O'Connor, K. W.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
    Journal Article

    Al-Ahmadie, H.; Iyer, G.; Hohl, M.; Asthana, S.; Inagaki, A.; Schultz, N.; Hanrahan, A. J.; Scott, S. N.; Brannon, A. R.; McDermott, G. C.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors
    Journal Article

    Feldman, D. R.; Iyer, G.; Van Alstine, L.; Patil, S.; Al-Ahmadie, H.; Reuter, V. E.; Bosl, G. J.; Chaganti, R. S.; Solit, D. B.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Mano, R.; Ciriello, G.; Gonen, M.; Mikkilineni, N.; Sfakianos, J. P.; Kim, P. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • Integrated analysis of metastatic disease in clear cell renal cell carcinoma: A collaborative TCGA analysis
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mano, R.; Gonen, M.; Voss, M. H.; Reuter, V. E.; Rathmell, K.; Maranchie, J. K.; Appleman, L. J.; Tamboli, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
    Meeting Abstract

    Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Long-term survival rates after chemotherapy (CTx) in patients (pts) with nonseminomatous (NS) germ cell tumors (GCT) with teratoma (T)
    Meeting Abstract

    Patil, S.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of mutations in chromatin modifiers with poor survival in clear cell renal cell carcinoma: Analysis of the Cancer Genome Atlas Project
    Meeting Abstract

    Hakimi, A. A.; Ostrovnaya, I.; Voss, M. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save